###begin article-title 0
The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence
###end article-title 0
###begin p 1
Conceived and designed the experiments: GR LP LP. Performed the experiments: LP LR LP LM AC MR ME. Analyzed the data: PP LP LP MS. Contributed reagents/materials/analysis tools: AM. Wrote the paper: GR MS.
###end p 1
###begin p 2
###xml 275 276 275 276 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</underline>
###xml 293 294 293 294 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 301 302 301 302 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 766 771 <span type="species:ncbi:10090">mouse</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
MicroRNAs (miRNAs) are short 20-22 nucleotide RNA molecules that act as negative regulators of gene expression via translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis. The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 3'UTR is demonstrated. To validate the interaction miR-20a/3'UTR LRF miR-20a was over-expressed, either by transient transfection or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that other targets are cooperating. As LRF down-regulation/p19ARF induction is always accompanied by E2F1 down-regulation and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF. Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of view the discovery of new physiological "senescence inducer" appears to be promising as this molecule could be used as anticancer drug.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 117 119 117 119 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Po</underline>
###xml 145 146 145 146 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</underline>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Lin1">[1]</xref>
###xml 408 409 408 409 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 422 423 422 423 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</underline>
###xml 431 432 431 432 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</underline>
###xml 436 437 436 437 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 524 527 524 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Chen1">[2]</xref>
###xml 529 532 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Chen2">[3]</xref>
###xml 544 547 544 547 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B c</underline>
###xml 551 552 551 552 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</underline>
###xml 560 561 560 561 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</underline>
###xml 611 614 611 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Ye1">[4]</xref>
###xml 653 654 653 654 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</underline>
###xml 671 672 671 672 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 679 680 679 680 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 897 900 897 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Davies1">[5]</xref>
###xml 902 905 902 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Laudes1">[6]</xref>
###xml 907 910 907 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Liu1">[7]</xref>
###xml 1016 1025 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lckE&#181;</italic>
###xml 1113 1116 1109 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda1">[8]</xref>
###xml 1257 1260 1253 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 1402 1406 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Palmero1">[10]</xref>
###xml 1567 1570 1563 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 804 809 <span type="species:ncbi:9606">human</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
Pok proteins are a group of bifunctional proteins with potential oncogenic properties. They consist of an N terminal Poz domain and a C terminal kruppel-type (C2H2) zinc finger domain. The C-terminal zinc finger mediates specific DNA recognition and binding, while the amino-terminal POZ domain recruits histone deacetylase repressing transcription [1]. The oncogenic members of the Pok family include PLZF (Promyelocytic Leukemia Zinc Finger), whose t(11:17) translocation is at the basis of acute promyelocytic leukaemia, [2], [3] and BCL-6 (B cell Lymphoma 6), which is deregulated in many types of lymphoma [4]. Another member of the family is LRF (Leukemia/lymphoma Related Factor) encoded by the zbtb7a gene and localized on chromosome 19p13.3 which is a hot spot for chromosomal translocations in human tumors. This protein, already known to have pleiotropic functions during embryogenesis [5], [6], [7], has recently been shown to act as an oncogene. When LRF is over-expressed in B and T lymphoid lineages (lckEmicro-LRF), mice develop aggressive lymphomas that cause death between 9 and 40 weeks of age [8]. Like the other members of the family, LRF is a transcriptional repressor and p19ARF has recently been found to be a specific target in MEF [9]. p19ARF oncosuppressor is known as a key mediator of cell senescence. It mainly acts by inhibiting MDM2 and in turn up-regulating p53 levels [10]. LRF over-expression keeps p19ARF level down,preventing the onset of the senescence program and allowing single oncogenic proteins such as Ras to transform MEF [9].
###end p 4
###begin p 5
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda1">[8]</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Although it has been shown that LRF is over-expressed in some human cancers [8], little is known about the mechanisms causing its up-regulation.
###end p 5
###begin p 6
###xml 243 247 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Bartel1">[11]</xref>
###xml 558 562 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Engels1">[12]</xref>
MicroRNAs (miRNAs) have recently come into focus as a novel class of post-transcriptional regulatory elements. They are abundant endogenous approximately22-nucleotides (nt) RNAs that repress mRNA translation by base pairing to 3'UTR sequences [11]. The miRNA-target recognition is mainly due to the perfect complementarity between a short 7-8 nt stretch at 5' end of the miRNA molecule (miRNA seed) and the corresponding stretch on the 3'UTR of the target gene (seed match). This results in a reduced translation and in turn a decreased level of the protein [12].
###end p 6
###begin p 7
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-He1">[13]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Venturini1">[14]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Hayashita1">[15]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Shao1">[16]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Calin1">[17]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Lin2">[18]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Eiriksdottir1">[19]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Some of the most studied microRNAs involved in human cancer are those belonging to miR-17-92 cluster. This cluster is located in a region amplified in lymphoma [13], [14] and lung cancers [15] while in other types of cancer, including nasopharyngeal carcinoma [16], [17], hepatocellular carcinoma [18] and breast cancer [19], the genomic location of the miR-17-92 cluster undergoes loss of heterozygosity suggesting that it may behave both as oncogene and oncosuppressor.
###end p 7
###begin p 8
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-He1">[13]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-ODonnell1">[20]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Sylvestre1">[21]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Dews1">[22]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Woods1">[23]</xref>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Enforced expression of the miR-17-92 cluster along with c-Myc expression accelerates tumor development in a mouse B-cell lymphoma model [13]. The underlying mechanism of action appears to be the E2F1 down-regulation by two members of the cluster, miR-17 and miR-20a. This c-Myc/miR-17-92 circuit helps to maintain E2F1 protein level below a pro-apoptotic threshold and cell proliferation prevails [20], [21], [22], [23].
###end p 8
###begin p 9
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Hossain1">[24]</xref>
On the other hand, in breast cancer cells the most relevant target of miR-17 is not E2F1, but AIB1. The nuclear receptor coactivator, amplified in breast cancer 1 (AIB1), acts as an oncogene. It actually enhances the transcriptional activity of many transcription factors, among which the estrogen receptor. Indeed, when miR-17 is over-expressed in breast cancer cells, a big decrease in ER-mediated signaling and in turn proliferation is observed and cells loose their ability to form colonies in soft agar [24].
###end p 9
###begin p 10
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Here, we report a novel activity exerted by miR-20a in mouse embryonic fibroblasts (MEF). This microRNA is able to control LRF protein at the post-transcriptional level and, when over-expressed, it induces premature senescence. This effect appears to be due to p19ARF up-regulation accompanied by up-regulation of p16 and down-regulation of E2F1.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 53 56 53 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
We utilized early passages MEF, known to express LRF [9], to investigate whether this anti-senescence gene is regulated by miRNAs.
###end p 12
###begin title 13
miR-20a regulates LRF protein at the post-transcriptional level
###end title 13
###begin p 14
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 194 203 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1a</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Altuvia1">[25]</xref>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 381 390 381 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1b</xref>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 749 758 749 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1d</xref>
###xml 771 780 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1e</xref>
###xml 798 807 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1f</xref>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
In silico analysis with TargetScanS () indicated various miRNA families potentially targeting the mouse zbtb7a 3'UTR. We focused our attention on the miR-17 family whose members are reported in Figure 1a[25]. Before testing if mouse zbtb7a 3'UTR interacts with miR-17 family members, the expression of representative members of the family was ascertained by RT-PCR. As reported in Figure 1b, MEF express the precursor of miR-20a, miR-17 and miR-106b, while they do not express the precursor of miR-106a. We then tested whether mouse zbtb7a 3'UTR interacts with miR-20a, miR-17 and miR-106b, using an EGFP reporter assay. miRNA-expressing plasmids (p-miRs) were investigated for their ability to inhibit fluorescence and it was found that p-miR-20a (Figure 1d), p-miR-17 (Figure 1e) and p-miR-106b (Figure 1f) all inhibit in a dose dependent manner.
###end p 14
###begin title 15
miR-20a regulates LRF expression in MEF.
###end title 15
###begin p 16
###xml 447 450 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmu</italic>
###xml 451 457 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 523 529 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 800 806 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 1143 1149 1125 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 1161 1167 1143 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 1173 1174 1155 1156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1468 1474 1450 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 1486 1492 1468 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 1498 1499 1480 1481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
a: Sequences of miRNAs belonging to miR-17 family; b: RT-PCR analysis of pri-miRNA expression in MEF. Total RNA was extracted and amplified by RT-PCR using appropriate primers. The PCR products of approximately500 bp length are pri-miRNAs of the miR-17 family; c: Northern blot analysis of mature miR-20a expression in MEF. 20 microg of total RNA was analyzed with miR-20a probe or valine tRNA control probe; d, e, f: Interaction between 3'UTR of mmu-zbtb7a mRNA and miR-17 family. HEK293T cells were co-transfected with p-zbtb7a 3'UTR and increasing concentrations of p-miR-20a, p-miR-17 p-miR-106b or p-miR-26a control plasmid. 24 hours after transfection, cells were collected and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression of p-zbtb7a 3'UTR was obtained by the ratio of the mean fluorescence value of HEK293T cells transfected with p-miR-20a, p-miR-17 or p-miR-106b and the mean fluorescence value of HEK293T cells transfected with p-miR-26a control plasmid. Each bar represents the mean+/-SE of three independent experiments; g,: Transfection of p-miR-20a with either p-zbtb7a 3'UTR or p-zbtb7a 3'UTRm in HEK293T. Cells were collected 24 hours after transfection and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression was obtained by the ratio of the mean fluorescence values of HEK293T cells cotransfected with p-miR-20a and either p-zbtb7a 3'UTR or p-zbtb7a 3'UTRm normalized to that of HEK293T cells transfected with pEGFPC1. Each bar represents the mean+/-SE of three independent experiments. h i: Effects of over-expression/depletion of miR-20a on LRF expression.
###end p 16
###begin p 17
###xml 150 159 150 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1c</xref>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 451 452 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 489 498 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1g</xref>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
Since we decided to focus on miR-20a throughout the experiments, the presence of the mature form in MEF cells was first ascertained by Northern blot (Figure 1c). To demonstrate the direct interaction, we again used the EGFP reporter assay. p-miR-20a was tested against p-zbtb7a 3'UTR wild type or mutated at the two binding sites specific for miR-17 family. p-miR-20a/p-zbtb7a 3'UTR interaction reduced the fluorescence, while p-miR-20a/p-zbtb7a 3'UTRm interaction rescues the inhibition (Figure 1g) indicating that miR-20a binds directly zbtb7a 3'UTR.
###end p 17
###begin p 18
###xml 171 180 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1h</xref>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1i</xref>
Gain and loss of functions experiments were then performed. We observed that miR-20a over-expression, by transfection of 80 nM mature miR-20a, reduces LRF protein by 40% (Figure 1h). Conversely, inhibition of endogenous miR-20a by transfection with 80 nM antisense 2'-O-methyl-oligoribonucleotide (decoy, d-20a) increases LRF protein level by 55% (Figure 1i).
###end p 18
###begin title 19
miR-20a over-expression induces p19ARF
###end title 19
###begin p 20
###xml 72 75 72 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 267 276 267 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2a</xref>
###xml 361 370 361 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2a</xref>
###xml 385 396 385 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2b,c</xref>
###xml 570 581 570 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2b,c</xref>
LRF has been shown to be a specific transcriptional repressor of p19ARF [9]. The transient over-expression of miR-20a shows that 48 hours post transfection the level of LRF mRNA was almost unchanged, while it was reduced following a si-RNA specific for LRF, si-LRF, (Figure 2a). p19ARF was more strongly up-regulated by si-LRF than by miR-20a at both the mRNA (Figure 2a) and protein (Figure 2b,c) levels in agreement with the degree of LRF inhibition. Downstream of p19ARF, p53 expression level was slightly increased while p21 level remained similar to control cells (Figure 2b,c).
###end p 20
###begin title 21
Effects of miR-20a on LRF-p19ARF pathway.
###end title 21
###begin p 22
a: q-RT-PCR of LRF, p19ARF and p21. Total RNA was extracted from MEF transfected with miR-20a, si-LRF or si-EGFP. mRNA level, detected by Real-Time PCR, was normalized to that of GAPDH. The values are the mean of two independent experiments. Western blot (b) and quantification (c) of LRF, p19ARF, p53 and p21. The band intensity was normalized to that of tubulin. Each bar represents the mean relative expression of LRF+/-SE of three independent experiments.
###end p 22
###begin title 23
miR-20a over-expression decreases cell proliferation and induces senescence
###end title 23
###begin p 24
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 299 308 299 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3a</xref>
###xml 488 497 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3b</xref>
###xml 516 525 510 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3c</xref>
The p19ARF up-regulation is known to inhibit MEF proliferation and to trigger senescence [9]. For this reason we investigated the effect of miR-20a on these two biological end points in MEF at early passages. MEF transfected with miR-20a proliferated less than those transfected with control miRNA (Figure 3a). To evaluate senescence, the number of SA-beta-gal positive and binucleated cells was determined 96 hours post transfection. miR-20a significantly enhanced SA-beta-gal positive (Figure 3b) and binucleated (Figure 3c) cells over control level. It can be noted that si-LRF was less efficient than miR-20a despite the stronger induction of p19ARF.
###end p 24
###begin title 25
miR-20a induces senescence in MEF.
###end title 25
###begin p 26
Detection of cell proliferation (a), SA-ss-gal positive (b) and binucleated (c) cells in wt MEF transfected with miR-20a. Detection of proliferation (d) and SA-ss-gal positive (e) cells in wt and LRF-null MEF retrovirally infected with PIG/miR-20a. Each bar represents the mean+/-SE of three independent experiments.
###end p 26
###begin p 27
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3d</xref>
###xml 363 372 360 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3e</xref>
###xml 511 520 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3e</xref>
###xml 681 690 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2e</xref>
To reinforce the finding that miR-20a induced senescence, LRF positive and null-LRF MEF were infected with a retrovirus expressing miR-20a (PIG/miR-20a) in order to achieve a stable expression. The results show that PIG/miR-20a markedly inhibits cell proliferation (Figure 3d), and it increases the percentage of SA-beta-gal positive cells two fold over control (Figure 3e). Interestingly, PIG/miR-20a is still able to cause a statistically significant increase in SA-beta-gal positive cells in LRF-null cells (Figure 3e). These data and data from transient trasfection experiments, showing that miR-20a over-expression induces a greater percentage of senescent cells than si-LRF (Figure 2e), indicate that although LRF is target of miR-20a, the modulation of other targets contributes to the senescent effect.
###end p 27
###begin title 28
miR-20a over-expression affects the expression of p16INK4a and E2F1
###end title 28
###begin p 29
###xml 318 330 318 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4 a,b</xref>
###xml 489 498 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4c</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-ODonnell1">[20]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Sylvestre1">[21]</xref>
E2F1, which plays a crucial role in senescence, is a known target of miR-20a. For this reason, the expression of E2F1 after miR-20a transient over-expression in MEF or stable expression in wild type and LRF-null MEF was determined. The results clearly indicate that miR-20a decreases E2F1 protein level in both cases (Figure 4 a,b). The depletion of the endogenous miR-20a with d-20a slightly enhanced the expression of E2F1 thus confirming that E2F1 is potentially under miR-20a control (Figure 4c). [20], [21]
###end p 29
###begin title 30
miR-20a regulates E2F1.
###end title 30
###begin p 31
Western blot analysis showing the expression of LRF and E2F1 in wt (a) and LRF-null MEF (b) retrovirally infected with PIG/miR-20a; c: Western blot analysis showing the expression of E2F1 in MEF transfected with d-20a; d: Western blot analysis showing the expression of E2F1 and p19ARF in wt MEF transfected with si-LRF, si-E2F1, si-EGFP and miR-20a; e: percentage of SA-ss-gal positive cells in wt MEF transfected with si-LRF, si-E2F1, si-EGFP and miR-20a.
###end p 31
###begin p 32
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4d</xref>
###xml 290 299 290 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4e</xref>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
We therefore asked whether E2F1 down-regulation per se contributed to senescence. MEF were transfected with si-E2F1: the expression of E2F1 was reduced but the reduction was not accompained by p19ARF upregulation (Figure 4d). In agreement with this result senescent cells were not induced (Figure 4e) demonstrating that E2F1 down-regulation is not enough per se to induce senescence.
###end p 32
###begin p 33
###xml 202 214 202 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5 a,b</xref>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5c</xref>
We asked whether another key senescence inducer, the tumor suppressor p16, might be induced by miR-20a over-expression. We found that only miR-20a and not si-LRF is able to increase p16 protein levels (Figure 5 a,b). Moreover, transient miR-20a transfection in LRF-null MEF demonstrates that miR-20a is able to induce p16 also in the absence of LRF (Figure 5c).
###end p 33
###begin title 34
miR-20a regulates p16.
###end title 34
###begin p 35
Western blot analysis showing the expression of p16 after miR-20a transfection in wt MEF (a,b) and in LRF-null MEF (c). Each bar represents the mean+/-SE of three independent experiments.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Parrinello1">[26]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Serrano1">[27]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Takahashi1">[28]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Yogev1">[29]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Kamijo1">[30]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Carnero1">[31]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Palmero1">[10]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Lloyd1">[32]</xref>
###xml 909 913 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Kamijo1">[30]</xref>
The persistent mitogenic stimulation during the propagation in culture induces senescence in MEF [26]. Senescence is also induced by cellular stresses such as the over-expression of single oncogenes [27], free radicals [28], or DNA damaging drugs [29]. While the culture induced senescence occurs after 5-6 passages in culture, the stress-induced senescence appears 48-72 hours after the insult. The induction of both types of senescence is mediated by the transcriptional activation of the INK4a locus and the consequent increase of the two encoded proteins p19ARF and p16INK4a [30], [31]; p19ARF protein up-regulates p53 levels by inhibiting MDM2 [10] while p16INK4a inhibits cyclin dependent kinases thereby activating the retinoblastoma protein [32]. Moreover p19ARF has been reported to associate with proteins other than MDM2 and to have p53-independent activities most of which remain to be elucidated [30].
###end p 37
###begin p 38
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 121 130 121 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 254 263 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1a</xref>
###xml 399 405 399 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 413 428 413 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1d,e,f,g</xref>
###xml 524 533 524 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1h</xref>
###xml 572 581 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2a</xref>
###xml 686 695 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g001">Figure 1i</xref>
The transcriptional repressor LRF prevents the senescence program in MEF by inhibiting p19ARF transcription [9]. From an in silico analysis we found that zbtb7a 3'UTR is predicted to be the target of several miRNA families, among which is miR-17 family (Figure 1a). Using a hybrid reporter assay, we were able to demonstrate that miR-17 family members, in particular miR-20a, interact directly with zbtb7a 3'UTR (Figure 1d,e,f,g). We also over-expressed miR-20a in MEF and found that LRF protein was consistently decreased (Figure 1h), while the mRNA level was unchanged (Figure 2a). Viceversa the depletion of the endogenous miR-20a by the antisense d-20a increased LRF protein level (Figure 1i). These results clearly demonstrate that in MEF LRF is under miR-20a control.
###end p 38
###begin p 39
###xml 111 122 111 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3b,e</xref>
Interestingly, we observed that the transient and stable miR-20a over-espression direct MEF toward senescence (Figure 3b,e), more similar to stress rather than to culture induced senescence, as it is accomplished within few days from transfection.
###end p 39
###begin p 40
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Mendell1">[33]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Tuccoli1">[34]</xref>
###xml 661 670 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2c</xref>
###xml 731 740 731 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">figure 3e</xref>
It is well known that miRNAs modulate the expression of several targets at once and in this way they activate or inhibit pathways [33], [34]. The final output depends on the fine-tuning of different players of the pathways. The miR-20a-induced senescence in MEF is not an exception to this rule. The results obtained following the stable and transient expression of miR-20a indicate the important role of LRF down-regulation/p19ARF up-regulation, but also suggest that other targets are involved. This assumption is based on the finding that miR-20a is a more powerful senescence inducer than si-LRF, although it is a milder inhibitor of LRF/inducer of p19ARF (Figure 2c) and that in LRF-null MEF additional senescence is induced (figure 3e).
###end p 40
###begin p 41
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-ODonnell1">[20]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Sylvestre1">[21]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Woods1">[23]</xref>
###xml 228 237 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4a</xref>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4b</xref>
###xml 456 465 456 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4c</xref>
Looking for other possible miR-20a targets, we focused our attention on E2F1, already known to be under miR-17 family control [20], [21], [23]. We confirmed that, when miR-20a is over-expressed either by transient transfection (Figure 4a) or stable infection (Figure 4b), E2F1 is invariably decreased. Furthermore, when endogenous miR-20a is depleted by decoy, E2F1 protein level is slightly increased confirming that E2F1 is under miR-20a control in MEF (Figure 4c).
###end p 41
###begin p 42
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Bates1">[35]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Dimri1">[36]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Palmero1">[10]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Martelli1">[37]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Mason1">[38]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Rizos1">[39]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maehara1">[40]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Park1">[41]</xref>
###xml 673 682 673 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4d</xref>
###xml 840 851 840 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4a,b</xref>
###xml 1130 1136 1130 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 1173 1182 1173 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g004">Figure 4e</xref>
###xml 1303 1312 1303 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3e</xref>
###xml 1393 1397 1393 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Canepa1">[42]</xref>
###xml 1418 1429 1418 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5a,b</xref>
###xml 1449 1458 1449 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5c</xref>
###xml 1649 1653 1649 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Takahashi1">[28]</xref>
###xml 1730 1734 1730 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Takahashi1">[28]</xref>
###xml 1790 1794 1790 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Iida1">[43]</xref>
###xml 1796 1800 1796 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Yang1">[44]</xref>
###xml 1913 1922 1913 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g003">Figure 3c</xref>
###xml 2183 2186 2183 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 2256 2265 2256 2265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g002">Figure 2c</xref>
###xml 2280 2289 2280 2289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5a</xref>
###xml 2357 2366 2357 2366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5a</xref>
###xml 2386 2395 2386 2395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002542-g005">Figure 5c</xref>
###xml 2587 2591 2587 2591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Thalmeier1">[45]</xref>
###xml 2593 2597 2593 2597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Adams1">[46]</xref>
###xml 2771 2775 2771 2775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Guney1">[47]</xref>
The role of E2F1 in senescence is controversial. p19ARF is under the transcriptional control of E2F1 [35] and this explains how premature senescence can be induced by oncogenic stresses, among which E2F1 over-expression [36]. Nonetheless, in an E2F1-null setting, proper stimuli can still induce p19ARF and senescence [10]. Moreover, p19ARF can in turn decrease E2F1 protein level/activity [37], [38], [39]. Also, in some cellular context the down-regulation of E2F1 is a necessary prerequisite for senescence [40], [41]. In agreement with an anti-senescence role of E2F1, we found that si-LRF transfection slightly increases MEF senescence and induces a decrease of E2F1 (Figure 4d), possibly p19ARF-dependent. On the other hand miR-20a was able to induce a more profound E2F1 down-regulation than si-LRF both in wt and in LRF-null cells (Figure 4a,b), possibly by direct binding of this microRNA to the 3'UTR of E2F1 mRNA. These data strongly suggest that miR-20a induced premature senescence is due to the cooperation of LRF and E2F1 down-regulation. This hypothesis is supported by the finding that E2F1 knock-down by si-E2F1 per se is not enough to induce senescence (Figure 4e) and by the significant increase of senescence in LRF-null MEF over-expressing miR-20a concomitant with E2F1 reduction (Figure 3e). We also found that miR-20a increases another important senescence player, p16 [42], in both wild type (Figure 5a,b) and LRF-null MEF (Figure 5c). Recently the p16 pathway has been shown to have a central role in induction of premature senescence establishing an autonomous activation of ROS production via inhibition of E2F1 activity [28]. This circuit leads at the end to a cytokinesis block due to PKC activation [28] and a inhibition of mitotic exit network kinase, WARTS [43], [44]. Although we have not investigated these activities, the significant induction of binucleated cells by miR-20a (Figure 3c) and the decrease in E2F1 level are consistent with the activation of the p16 pathway as well. LRF down-regulation does not seem to play a role in p16 induction, because it has been previously reported to specifically inhibit p19ARF, but not p16 transcription [9]. We observed that, as opposed to miR-20a, si-LRF causes only p19ARF (Figure 2c) and not p16 (Figure 5a) up-regulation. Furthermore, p16 is induced by miR-20a in both wt (Figure 5a) and LRF-null MEF (Figure 5c). A plausible hypothesis is that miR-20a directly or indirectly affects a negative regulator of p16. In this respect, it is of note that E2F1 and c-Myc are linked by a positive feedback loop [45], [46], so that miR-20a-induced E2F1 down-regulation might decrease c-Myc level. Reduced c-Myc level has been shown to trigger senescence by inducing p16 via Bmi-1 down-regulation [47]. In our case the concomitant downregulation of E2F1 accompanied by p16 up-regulation are events which cooperate with LRF down-regulation to induce senescence. The combined modulation of these different proteins is likely to be at the basis of the senescence pathways elicited by miR-20a-over-expression.
###end p 42
###begin p 43
In conclusion our data demonstrate that in MEF at early passages miR-20a is able to induce cellular senescence. The direct down-regulation of LRF, with the consequent induction of p19ARF, is a key mediator of the process, but the cooperation with other pathways, represented by E2F1 down-regulation and p16 up-regulation, appears to contribute. The finding that miR-20a is able to induce premature senescence is, in our opinion, interesting as it may have potential clinical relevance as anti-tumorigenic drug.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Reagents
###end title 45
###begin p 46
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ambion</italic>
###xml 84 104 84 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amersham Biosciences</italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clontech</italic>
###xml 169 178 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dharmacon</italic>
###xml 248 263 248 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGTM, IFC, Pisa</italic>
###xml 284 304 282 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gene Therapy Systems</italic>
###xml 515 525 511 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Invitrogen</italic>
###xml 538 543 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIDMC</italic>
###xml 545 551 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boston</italic>
###xml 553 556 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USA</italic>
###xml 617 641 613 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Santa Cruz Biotechnology</italic>
###xml 643 647 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inc.</italic>
###xml 671 676 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abcam</italic>
###xml 699 713 695 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cell Signaling</italic>
###xml 726 737 722 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Novo Castra</italic>
###xml 766 769 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEB</italic>
###xml 861 867 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QIAGEN</italic>
###xml 975 980 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Roche</italic>
###xml 1065 1070 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sigma</italic>
###xml 1165 1175 1157 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stratagene</italic>
###xml 1205 1216 1197 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIOCOAT, BD</italic>
###xml 1261 1279 1253 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Applied Biosystems</italic>
###xml 495 501 <span type="species:ncbi:9913">bovine</span>
###xml 881 887 <span type="species:ncbi:9913">bovine</span>
Ultrahyb Oligo solution (Ambion); Nylon membrane Hybond-C extra, ECL detection kit (Amersham Biosciences); pEGFP-C1 plasmid (Clontech); mature miR-20a, si-EGFP, si-LRF (Dharmacon); antisense 2'-O-methyl-oligoribonucleotide against miR-20a (d-20a) (LGTM, IFC, Pisa); Gene Silencer(R) (Gene Therapy Systems); lipofectamine 2000, Trizol(R) Reagent DNAseI amplification grade, SuperScript II reverse transcriptase, Taq DNA polymerase, Dulbecco's Modified Eagle Medium-High Glucose (D-MEM-HG), fetal bovine serum (FBS) (Invitrogen); anti-LRF (BIDMC, Boston, USA); anti-E2F1 (sc-193) anti-p16 (sc-1661), anti-p21 (sc-397) (Santa Cruz Biotechnology, Inc.,); anti-p19ARF (ab80) (Abcam); anti-GAPDH (14C10) (Cell Signaling); anti-p53 (Novo Castra); T4 polynucleotide kinase (NEB); RNeasy mini kit for isolation of total RNA from animal cells, Polyfect, miScript System (QIAGEN); fraction V bovine serum albumin (BSA); LightCycler 480 Probes Master, Universal ProbeLibrary LNA Probes (Roche); X-Gal (5-bromo-4-chloro-3-indolylb-D-galactoside); anti-alpha-tubulin; polybrene (Sigma); pCMV-MCS plasmid, Herculase DNA polymerase, QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene); poly-D-Lysine coated dish (BIOCOAT, BD); ABI PRISM 7700 Sequence Detection System (Applied Biosystems).
###end p 46
###begin title 47
Cells and culture conditions
###end title 47
###begin p 48
###xml 635 636 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 839 840 827 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 387 393 <span type="species:ncbi:9913">bovine</span>
Wt and LRF-null mouse embryonic fibroblasts (MEF) were isolated from 13.5d mouse embryos. Briefly, embryos were mechanically fragmented and then incubated with trypsin (0.25% in PBS pH 7.5) at 37degreesC for 15-20 minutes with a magnetic stirrer. After 10 minutes centrifugation at 290xg, pellets were resuspended in Dulbecco's Modified Eagle Medium+High Glucose (DMEM-HG) without fetal bovine serum (FBS) and centrifuged for 10 minutes at 290xg. After three washings, the cell suspension was distributed in culture dish containing complete DMEM-HG+10% FBS. Cells were trypsinized at confluency (p1). The propagation protocol 3T6 (6x105 cells/100 mm diameter dish transferred every 3 days) was followed. HEK 293T and Phoenix E cells were grown in DMEM+10% FBS. All cells were grown at 37degreesC in a humidified atmosphere containing 6% CO2.
###end p 48
###begin title 49
Plasmids
###end title 49
###begin p 50
###xml 11 21 11 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmu-zbtb7a</italic>
###xml 94 128 88 122 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAG AAG CAC TTT AAG GAC GAG- 3&#8242;</named-content>
###xml 137 169 131 163 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAT AGG AAG GCA AAG AGC A -3&#8242;</named-content>
###xml 191 192 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 449 455 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 518 524 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 530 531 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 566 572 554 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 752 758 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 768 807 756 795 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCCCACTTTTTAAGT*T*AG*TTTTTAGATCG-3&#8242;</named-content>
###xml 820 860 808 848 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCATCTAAAAAC*TA*A*CTTAAAAAGTGGGGA-3&#8242;</named-content>
###xml 904 944 892 932 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGGGGATCTTGGCAT*A*TG*GTAACTGAACGG-3&#8242;</named-content>
###xml 957 999 945 987 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGTTCAG TTAC C*AT*A*TGCCAAGATCCCCAC-3&#8242;</named-content>
The entire mmu-zbtb7a 3'UTR (Acc Ndegrees NM_010731) was obtained by PCR from genomic DNA. F (5'-GAG AAG CAC TTT AAG GAC GAG- 3') and R (5'-GAT AGG AAG GCA AAG AGC A -3') primers were used (Ta 57degreesC). The fragment was cloned downstream of EGFP ORF within pEGFP-C1 plasmid and a stop codon was inserted between the EGFP and the target fragment, so that the transcribed mRNA is a hybrid molecule but the translated protein is EGFP. The plasmid p-zbtb7a 3'UTR was constructed. The mutated version of this plasmid (p-zbtb7a 3'UTRm) was generated by utilizing the p-zbtb7a 3'UTR as template and modifying the miR-20a seed binding site using the QuikChange II XL Site-Directed Mutagenesis Kit. The mutagenic primers used were: site1 (position 2764 mRNA zbtb7a) forward 5'-TCCCCACTTTTTAAGT*T*AG*TTTTTAGATCG-3' and reverse 5'- GCATCTAAAAAC*TA*A*CTTAAAAAGTGGGGA-3'; site2 (position 3061 mRNA Zbtb7a) forward 5'-GTGGGGATCTTGGCAT*A*TG*GTAACTGAACGG-3' and reverse 5'-CCGTTCAG TTAC C*AT*A*TGCCAAGATCCCCAC-3', where the asterisks indicate the mutated bases.
###end p 50
###begin p 51
###xml 172 198 172 198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTGGAACTTCTGGCTATTG-3&#8242;</named-content>
###xml 207 230 207 230 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCTGCAAACACAACTA-3&#8242;</named-content>
###xml 251 273 251 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCGTCGGTCAGTCG-3&#8242;</named-content>
###xml 282 310 282 310 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAAACCTGCAAAACTAACCATA-3&#8242;</named-content>
###xml 332 358 332 358 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGATTGCCAGTGTTATTC-3&#8242;</named-content>
###xml 367 391 367 391 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAGAAGTAGCCTGTGCG-3&#8242;</named-content>
###xml 414 438 414 438 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGCATATGTGGAGATG-3&#8242;</named-content>
###xml 447 472 447 472 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAGCAGTAGGTACGGTAA-3&#8242;</named-content>
###xml 495 519 495 519 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCACTGCTGACCCATTCT-3&#8242;</named-content>
###xml 528 552 528 552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGACTCCTCGTTGCCAG-3&#8242;</named-content>
###xml 874 879 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 884 888 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XhoI</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 969 972 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Genomic fragments of about 500 bp which contained human pri-miR-17, pri-miR-20a, pri-miR-106a, pri-miR-106b or pri-miR-26a sequences were obtained by PCR. Primers were: F (5'-TTTGGAACTTCTGGCTATTG-3') and R (5'-GGCTGCAAACACAACTA-3') for pri-miR-17; F (5'-AGTCGTCGGTCAGTCG-3') and R (5'-CAAACCTGCAAAACTAACCATA-3') for pri-miR-20a; F (5'-TGAGATTGCCAGTGTTATTC-3') and R (5'-TAAGAAGTAGCCTGTGCG-3') for pri-miR-106a; F (5'-GCAGCATATGTGGAGATG-3') and R (5'-TCAGCAGTAGGTACGGTAA-3') for pri-miR-106b; F (5'-CCACTGCTGACCCATTCT-3') and R (5'-AAGACTCCTCGTTGCCAG-3') for pri-miR-26a. Annealing temperatures were: 54.9degreesC for pri-miR-17, 54.2degreesC for pri-miR-20a, 57.6degreesC for pri-miR-106b, and 57degreesC for pri-miR-26a. F primers were elongated at the 5' ends to include the GGATCC sequence and R primers were elongated at 5' ends to include the CTCGAG sequence to create BamHI and XhoI restriction sites, respectively. The PCR products were cloned downstream of the CMV promoter within the pCMV-MCS plasmid. In this way, the expression plasmids nick-named p-miR-20a, p-miR-17, p-miR-106b and p-miR-26a were obtained.
###end p 51
###begin p 52
###xml 86 113 86 113 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8211;TATTTCCTTCAAATGAATGAT-3&#8242;</named-content>
###xml 120 147 120 147 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCAGTAACAGGACAGTTTGA-3&#8242;</named-content>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002542-Maeda2">[9]</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
pri-miR20a was amplified by PCR from genomic human DNA using the following primers: F 5'-TATTTCCTTCAAATGAATGAT-3' and R 5'-TTCAGTAACAGGACAGTTTGA-3'. The sequence was then subcloned into MSCV-PIG [9] using BglII and XhoI (PIG/miR-20a).
###end p 52
###begin title 53
RT-PCR
###end title 53
###begin p 54
To detect the expression of pre-miRNAs, total RNA was extracted from MEF using the RNeasy mini kit. After DNase treatment, 1 microg RNA was retrotranscribed using SuperScript II reverse transcriptase. The primers were those used for cloning. 2 microl of the RT mixture was then added in 50 microl PCR reactions and 7 microl aliquots were loaded on gel.
###end p 54
###begin title 55
Northern blot
###end title 55
###begin p 56
###xml 173 174 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 291 320 287 316 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTACCTGCACTATAAGCACTTTA-3&#8242;</named-content>
###xml 360 362 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 535 536 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 720 749 696 725 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAACGTGATAACCACTACACTAC-3&#8242;</named-content>
###xml 764 790 740 766 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTGCTGCCGAAGCAAGCAC-3&#8242;</named-content>
20 microg of total RNA, extracted using the Trizol reagent, were loaded onto a 15% polyacrylamide 7 M urea gel, electrophoresed and successively electroblotted onto Hybond N+ membrane. The oligonucleotide used as probe was the complementary sequence of the mature miR-20a (miRNA Registry): (5'-CTACCTGCACTATAAGCACTTTA-3'). Probes were end-labelled with [gamma-32P]ATP (300 Ci/mmole) by T4 polynucleotide kinase. Prehybridization and hybridization were carried out in Ultrahyb Oligo solution containing 25 microg salmon sperm DNA and 106 cpm/ml labelled probes at 37degreesC overnight. Washing was performed in 6xSSPE at 37degreesC. As a loading control, membranes were stripped and re-hybridized with valine tRNA probe (5'-GAACGTGATAACCACTACACTAC-3') or U6 probe (5'-TGTGCTGCCGAAGCAAGCAC-3'). The image of Northern hybridization signals was obtained using a Phosphoimager (B4312 Cyclone, Packard).
###end p 56
###begin title 57
EGFP reporter assay
###end title 57
###begin p 58
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
HEK 293T cells were seeded at a density of 6x105 cells per 30 mm diameter dish. 24 hours later, 140 ng of p-zbtb7a 3'UTR were cotransfected with 75-300 ng of p-miR-17, p-miR-20a, p-miR-106 (specific miRNAs) or p-miR-26a not predicted by any algorithm to target the 3'UTR of LRF. The aspecific miRNA was used to normalize the fluorescence values. Polyfect was used as transfectant, according to the manufacturer's recommendations. 36 hours after transfection fluorescence was quantitated by cytofluorimetry (FACSCalibur, Becton Dickinson). 104 cells per sample were analysed.
###end p 58
###begin title 59
MEF transfection
###end title 59
###begin p 60
###xml 114 139 114 139 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAUAAAGAAGAGUGGGAAG-3&#8242;</named-content>
###xml 448 449 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 597 598 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 607 608 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Exponentially growing MEF at passage 2 were transfected with miR-20a, d-20a, siRNA-LRF, a siRNA specific for LRF (5'-CAUAAAGAAGAGUGGGAAG-3') or si-E2F1 (Dharmacon). Briefly, 15 microl Optimem and 25 microl transfection buffer plus 80 nM miRNA or d-20a were mixed with a solution of Gene Silencer (5 microl) plus Optimem (25 microl). After 15 minutes incubation, Optimem was added up to 800 microl. Then, the transfection mixture was added to 1.2x106 cells resuspended in 200 microl Optimem. After 5 min, 10 ml Optimem was added and the suspension distributed in culture dishes at a density of 2x104 cells/cm2. After 6 hours the medium was replaced with complete DMEM-HG. With this protocol more than 90% of MEF were transfected (data not shown). Cells were collected at specified time points after transfection and further analyzed.
###end p 60
###begin title 61
MEF retroviral infection
###end title 61
###begin p 62
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 375 376 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
For retrovirus-mediated gene transfer, Phoenix E cells (3x106) were plated in a 100 mm poly-D-Lysine coated dish and, 16 hours later, were transfected with retroviral plasmid (PIG/miR-20a) using Lipofectamine 2000. 48 hours later, the virus-containing medium (10 ml) was filtered, mixed with 5 ml of freshly prepared medium and supplemented with 4 microg / ml polybrene. 7x105 MEFs at passage 2 were plated in a 100 mm dish. 16 hours later, the medium was replaced with viral supernatant. Puromycin (2 microg /ml) was administered 48 hours after infection. The cells were subsequently selected for 2 days and then utilized for the various assays.
###end p 62
###begin title 63
Western blot
###end title 63
###begin p 64
Transfected cells grown for 48 hours in 100 mm diameter dishes were collected, centrifuged and lysed (20 mM Tris-HCl pH 8.0; 20 mM NaCl; 10% glycerol; 1% NP40; 10 mM EDTA; 2 mM PMSF, 2.5 microg/ml leupeptin). Infected cells were collected immediately at the end of antibiotic selection. Proteins (30 microg/lane) were separated on 12% SDS-polyacrylamide gel and transferred to nitrocellulose membrane.
###end p 64
###begin p 65
Immunoblotting of the membranes was performed using the following primary antibodies: anti-LRF (1:1000); anti-E2F1 (1:1000); anti-p16 (1:250); anti-p21 (1:1000); anti-p19ARF (1:1000); anti-p53 (1:1000); anti-alpha-tubulin (1:20000); anti-GAPDH (1:10000). Signals were revealed after incubation with recommended secondary antibody coupled to peroxidase by using enhanced chemiluminescence. Scanned images were quantified using Scion Image software.
###end p 65
###begin title 66
Real-time PCR analysis
###end title 66
###begin p 67
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19ARF</italic>
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zbtb7a</italic>
###xml 429 435 429 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19ARF</italic>
###xml 440 465 440 465 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATGGGTCGCAGGTTCTTG-3&#8242;</named-content>
###xml 471 496 471 496 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTCGCTGTCCTGGGTCTC-3&#8242;</named-content>
###xml 509 537 509 537 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACTGTGAGGATTCAGCGCGCG-3&#8242;</named-content>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRF</italic>
###xml 552 582 552 582 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AACTACGACCTGAAGAACCACATG-3&#8242;</named-content>
###xml 588 612 588 612 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGATGGTCGGAGCGCACA-3&#8242;</named-content>
###xml 625 656 625 656 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCGGCCATACCAGTG CGATAGC-3&#8242;</named-content>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 671 698 671 698 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCACAGCGATATCCAG ACA-3&#8242;</named-content>
###xml 704 730 704 730 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGACATCACCAGGATTGGAC-3&#8242;</named-content>
###xml 747 761 747 761 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCCCTGG-3&#8242;</named-content>
###xml 841 842 841 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 902 927 902 927 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCTTCCGTGTTCCTACCC-3&#8242;</named-content>
###xml 933 959 933 959 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCCTGCTT CACCACCTTC-3&#8242;</named-content>
###xml 972 1009 972 1009 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGGAGAAACCTGCCAAGTATGATGACATC-3&#8242;</named-content>
###xml 1160 1189 1160 1189 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAAGTGCTTATAGTGCAGGTAG-3&#8242;</named-content>
###xml 1194 1222 1194 1222 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCAAGGATGACACGCAAATTC-3&#8242;</named-content>
###xml 1367 1385 1367 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cellular read outs</italic>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
To evaluate mouse p19ARF, p21, and zbtb7a mRNA levels, total RNA was extracted from transfected MEF using Trizol reagent according to the manufacturer's instructions. DNase treatment and retrotranscription were performed as described above. Real-time PCR was carried out using ABI PRISM 7700 Sequence Detection System (Applied Biosystems) and LightCycler 480 (Roche). Taqman probes and oligonucleotides used were as follows: for p19ARF, F (5'-CATGGGTCGCAGGTTCTTG-3'), R (5'-GCTCGCTGTCCTGGGTCTC-3') and probe (5'-CACTGTGAGGATTCAGCGCGCG-3'); for LRF, F (5'-AACTACGACCTGAAGAACCACATG-3'), R (5'-AGATGGTCGGAGCGCACA-3') and probe (5'-CTGCGGCCATACCAGTG CGATAGC-3'); for p21, F (5'-TCCACAGCGATATCCAG ACA-3'), R (5'-GGACATCACCAGGATTGGAC-3') and LNA probe (5'-GGCCCTGG-3'). Relative quantitation of gene expression was performed with the comparative CT method. GAPDH was amplified with the following primers: F (5'-GCCTTCCGTGTTCCTACCC-3'), R (5'-TGCCTGCTT CACCACCTTC-3') and probe (5'-CCTGGAGAAACCTGCCAAGTATGATGACATC-3') and used as internal standard. Mature miR-20a was quantified using the miScript System according to the manifacturer's instruction. Oligonucleotides 5'-TAAAGTGCTTATAGTGCAGGTAG-3' and 5'-CGCAAGGATGACACGCAAATTC-3' were used as forward primers respectively of miR-20a and U6 in the real time amplification mixtures. All reactions were performed in triplicate Cellular read outs.
###end p 67
###begin title 68
Cell proliferation
###end title 68
###begin p 69
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
48 hours post-transfection, 1x105 cells were seeded in a series of 30 mm diameter dish and grown for 96 hours. At 24 hours intervals cells were collected and counted. Growth curves after infection were generated by seeding 2.5 104 cells per 12 well plates in triplicate for three independent experiments. Cells were subsequently fixed in paraformaldeyde at defined time points and subsequently stained with cristal violet. After lysis with acetic acid 10%, O.D. is read at 590 nm.
###end p 69
###begin title 70
Senescence-associated (SA) beta-galactosidase activity
###end title 70
###begin p 71
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 506 507 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
48 hours post-transfection, 4x104 cells were seeded in 30 mm diameter dish and 48 hours later dishes were washed once with PBS and fixed for 3-5 minutes at room temperature in PBS containing 2% formaldehyde/0.2% glutaraldehyde. Cells were then washed three times in PBS, and incubated at 37degreesC with fresh SA-beta-gal staining solution containing 1 mg/ml 5-bromo-4-chloro-3-indolyl P3-D-galactoside (X-Gal) (stock = 20 mg/ml in DMSO), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl2 in PBS pH6.0. SA-beta-gal positive cells were scored after 48 hours by counting 500 cells with normal light microscopy. For infection experiments, cells were plated as described above (Cell Proliferation) and were scored 5 days after plating.
###end p 71
###begin title 72
Binucleated cells
###end title 72
###begin p 73
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
48 hours post-transfection, 4x104 cells were seeded in 30 mm dish and 48 hours later dishes were washed with PBS and fixed for 10 minutes with formaldehyde at room temperature. Cells were then stained with 0.1% crystal violet/20% methanol for 15 min. Binucleated cells were scored counting 500 cells by normal light microscopy.
###end p 73
###begin title 74
Statistical analysis
###end title 74
###begin p 75
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data were analyzed using GraphPad prism (GraphPad Software, Inc., San Diego, CA). Statistical differences were determined by unpaired t-test, with values of P<0.05 considered statistically significant.
###end p 75
###begin p 76
###xml 89 94 <span type="species:ncbi:452646|species:ncbi:9666">Minks</span>
We thank P. Isola for technical support, L. Luzzatto for comments and suggestions and M. Minks for critical reading of the manuscript.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Role of the histone deacetylase complex in acute promyelocytic leukaemia.
###end article-title 78
###begin article-title 79
Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.
###end article-title 79
###begin article-title 80
MicroRNAs modulate hematopoietic lineage differentiation.
###end article-title 80
###begin article-title 81
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.
###end article-title 81
###begin article-title 82
Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
###end article-title 82
###begin article-title 83
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 68 74 <span type="species:ncbi:10090">murine</span>
Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis.
###end article-title 83
###begin article-title 84
Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis.
###end article-title 84
###begin article-title 85
The transcription factor Pokemon: a new key player in cancer pathogenesis.
###end article-title 85
###begin article-title 86
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.
###end article-title 86
###begin article-title 87
p19ARF links the tumour suppressor p53 to Ras.
###end article-title 87
###begin article-title 88
MicroRNAs: genomics, biogenesis, mechanism, and function.
###end article-title 88
###begin article-title 89
Principles and effects of microRNA-mediated post-transcriptional gene regulation.
###end article-title 89
###begin article-title 90
###xml 38 43 <span type="species:ncbi:9606">human</span>
A microRNA polycistron as a potential human oncogene.
###end article-title 90
###begin article-title 91
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
###end article-title 91
###begin article-title 92
###xml 65 70 <span type="species:ncbi:9606">human</span>
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
###end article-title 92
###begin article-title 93
High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China.
###end article-title 93
###begin article-title 94
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.
###end article-title 94
###begin article-title 95
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
###end article-title 95
###begin article-title 96
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
###end article-title 96
###begin article-title 97
c-Myc-regulated microRNAs modulate E2F1 expression.
###end article-title 97
###begin article-title 98
An E2F/miR-20a auto-regulatory feed-back loop.
###end article-title 98
###begin article-title 99
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
###end article-title 99
###begin article-title 100
Direct regulation of an oncogenic microRNA cluster by E2F transcription factors.
###end article-title 100
###begin article-title 101
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
###end article-title 101
###begin article-title 102
###xml 40 45 <span type="species:ncbi:9606">human</span>
Clustering and conservation patterns of human microRNAs.
###end article-title 102
###begin article-title 103
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts.
###end article-title 103
###begin article-title 104
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
###end article-title 104
###begin article-title 105
Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.
###end article-title 105
###begin article-title 106
Induction of transcriptionally active Jun proteins regulates drug-induced senescence.
###end article-title 106
###begin article-title 107
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
###end article-title 107
###begin article-title 108
Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.
###end article-title 108
###begin article-title 109
Limits to lifespan.
###end article-title 109
###begin article-title 110
MicroRNAs: critical regulators of development, cellular physiology and malignancy.
###end article-title 110
###begin article-title 111
miRNAs Regulate miRNAs: Coordinated Transcriptional and Post-Transcriptional Regulation.
###end article-title 111
###begin article-title 112
p14ARF links the tumour suppressors RB and p53.
###end article-title 112
###begin article-title 113
Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
###end article-title 113
###begin article-title 114
p19ARF targets certain E2F species for degradation.
###end article-title 114
###begin article-title 115
p14(ARF) regulates E2F activity.
###end article-title 115
###begin article-title 116
p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
###end article-title 116
###begin article-title 117
Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
###end article-title 117
###begin article-title 118
###xml 56 61 <span type="species:ncbi:9606">human</span>
E2F-1 is a critical modulator of cellular senescence in human cancer.
###end article-title 118
###begin article-title 119
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
###end article-title 119
###begin article-title 120
Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function.
###end article-title 120
###begin article-title 121
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Dicer is required for embryonic angiogenesis during mouse development.
###end article-title 121
###begin article-title 122
###xml 83 88 <span type="species:ncbi:9606">human</span>
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.
###end article-title 122
###begin article-title 123
Complex transcriptional regulatory mechanisms control expression of the E2F3 locus.
###end article-title 123
###begin article-title 124
Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).
###end article-title 124
###begin p 125
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 125
###begin p 126
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was in part supported by Associazione Italiana Ricerca sul Cancro (AIRC).
###end p 126

